American Society for Radiation Oncology (ASTRO) to host Annual Meeting in San Francisco, September 27-October 1
Meeting Announcement
Updates every hour. Last Updated: 11-Jul-2025 13:10 ET (11-Jul-2025 17:10 GMT/UTC)
Registration opens today for the 67th American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held at the Moscone Center in San Francisco, September 27 to October 1, 2025. Led by ASTRO President Sameer Keole, MD, FASTRO, the conference is centered around the theme of “Rediscovering Radiation Medicine and Exploring New Indications” and is expected to attract up to 10,000 oncologists, clinicians, researchers and other health care professionals from around the globe. ASTRO news briefings will feature noteworthy and high-impact research presented at the meeting; briefing details will be announced in early September.
Scientists at St. Jude Children’s Research Hospital showed how inheriting a deficient ELP1 gene increases the risk of SHH-driven pediatric medulloblastoma and further revealed that MDM2 inhibitors can help stop it.
A new study by investigators from Mass General Brigham suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM) — the most common and deadly form of brain cancer in adults. The findings, published in Nature Communications, are based on a retrospective analysis and add new evidence to help patients with this devastating disease.